Dimethyl fumarate versus interferon for treatment of relapsing-remitting multiple Sclerosis

被引：0
|
作者：
Sattarnezhad, Neda [1 ]
Healy, Brian C. [1 ,2 ]
Baharnoori, Moogeh [1 ]
Diaz-Cruz, Camilo [1 ]
Stankiewicz, James [1 ]
Weiner, Howard L. [1 ]
Chitnis, Tanuja [1 ,3 ]
机构：
[1] Brigham & Womens Hosp, Partners MS Ctr, Boston, MA 02115 USA
[2] MGH Biostat Ctr, Boston, MA USA
[3] Massachusetts Gen Hosp, Pediat MS Ctr, Boston, MA 02114 USA
来源：
NEUROLOGY | 2017年 / 88卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P6.381
引用
下载
收藏
页数：3
相关论文
共 50 条
  • [21] Dimethyl fumarate treatment of relapsing-remitting multiple sclerosis influences B-cell subsets
    Lundy, Steven K.
    Wu, Qi
    Wang, Qin
    Dowling, Catherine A.
    Taitano, Sophina H.
    Mao, Guangmei
    Mao-Draayer, Yang
    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2016, 3 (02):
  • [22] Dimethyl fumarate: A fumaric acid ester under investigation for the treatment of relapsing-remitting multiple sclerosis
    Sobieraj, Diana M.
    Coleman, Craig I.
    FORMULARY, 2012, 47 (11) : 386 - 391
  • [23] Dimethyl Fumarate: A Review of Its Use in Patients with Relapsing-Remitting Multiple Sclerosis
    Celeste B. Burness
    Emma D. Deeks
    CNS Drugs, 2014, 28 : 373 - 387
  • [24] COST-EFFECTIVENESS ANALYSIS OF DIMETHYL FUMARATE IN THE TREATMENT OF RELAPSING-REMITTING MULTIPLE SCLEROSIS IN ITALY
    Mantovani, L. G.
    Furneri, G.
    Cortesi, P. A.
    Puma, E.
    Santoni, L.
    Prosperini, L.
    VALUE IN HEALTH, 2019, 22 : S740 - S741
  • [25] Dimethyl Fumarate: A Review of Its Use in Patients with Relapsing-Remitting Multiple Sclerosis
    Burness, Celeste B.
    Deeks, Emma D.
    CNS DRUGS, 2014, 28 (04) : 373 - 387
  • [26] DIMETHYL FUMARATE VERSUS FINGOLIMOD AND TERIFLUNOMIDE FOR THE TREATMENT OF RELAPSING-REMITTING MULTIPLE SCLEROSIS IN COLOMBIA: A COST-UTILITY ANALYSIS
    Ordonez, J. E.
    VALUE IN HEALTH, 2017, 20 (05) : A194 - A194
  • [27] Interferon β treatment in relapsing-remitting multiple sclerosis.: A review
    Grigoriadis, N
    CLINICAL NEUROLOGY AND NEUROSURGERY, 2002, 104 (03) : 251 - 258
  • [28] THE COST EFFECTIVENESS OF BG-12 (DIMETHYL FUMARATE) FOR THE TREATMENT OF RELAPSING-REMITTING MULTIPLE SCLEROSIS IN CANADA
    Su, W.
    Walker, A.
    Sarda, S.
    Kansal, A. R.
    Vicente, C.
    Deniz, B.
    VALUE IN HEALTH, 2013, 16 (07) : A623 - A623
  • [29] Pharmacology and clinical efficacy of dimethyl fumarate (BG-12) for treatment of relapsing-remitting multiple sclerosis
    Ruggieri, Serena
    Tortorella, Carla
    Gasperini, Claudio
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2014, 10 : 229 - 239
  • [30] A case of Legionnaires' disease in a patient on dimethyl fumarate therapy for relapsing-remitting multiple sclerosis
    Brandstadter, R.
    Sand, I. Katz
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 871 - 872
12345